Our Services
Survival Rates
Children's Hospital of Pittsburgh of UPMC
2007 Patient Survival Rates*
Liver1 Year: 96% (national average: 92%)
3 Years: 95% (national average: 85%)
Intestine
1 Year: 90% (national average: 77%)
3 Years: 89% (national average: 59%)
Heart
4 Years: 84% (national average: 77%)
8 Years: 76% (national average: 69%)
Lung
Patients transplanted 2003–2006: 89%
Heart-Lung
Patients transplanted 2003–2006: 100%
Kidney
1 Year: 100% (national average: 98%)
3 Years: 100% (national average: 97%)
Bone and Marrow 2000-2005
| Outcome Measure |
Type of Transplant |
Children's Hosp. of Pgh. Survival Rate |
Published Data |
| 100-Day Survival 1 | All** | 92% | Variable*** |
| Myeloid Engraftment 2 | Cord Blood | 100% at 35 days |
88% at 45 days |
| One-Year Overall Survival 3 | All** | 75% | Variable*** |
Transplant Program Volumes
| Transplant Type | 2006 | Program Inception Through 12/31/2005 |
| Abdominal | ||
| Liver and Liver/Kidney | 22 | 1,197 |
| Living-Donor Liver | 10 | 30 |
| Liver/Small Bowel | 4 | 86 |
| Small Bowel/Multivisceral | 11 | 81 |
| Subtotal | 47 | 1,394 |
| Cardiopulmonary | ||
| Heart | 16 | 210 |
| Lung | 3 | 58 |
| Heart/Lung | 0 | 42 |
| Subtotal | 19 | 310 |
| Kidney | ||
| Living-Donor | 7 | 120 |
| Deceased-Donor | 14 | 232 |
| Subtotal | 21 | 352 |
| Blood and Marrow | ||
| Allo | 22 | 166 |
| Auto | 14 | 108 |
| Subtotal | 36 | 274 |
| Total | 123 | 2,330 |
1 Percentage of patients living one hundred or more days following the transplant procedure (This takes into account deaths due to transplant- and disease-related causes.)
2 Signs that the new bone marrow or stem cells are engrafting (growing and developing)
3 Percentage of patients living one or more years following the transplant procedure
* Sources: Internal data; Scientific Registry of Transplant Recipients(www.ustransplant.org)
** Includes auto-BMT, allo-related BMT, allo-unrelated and cord blood transplants.
*** Patient outcomes vary depending upon age, health status, diagnosis, disease status, type of transplant, degree of mismatch, CMV status and other factors.
